Adlai Nortye Doses First Patient in the P-I Trial of AN9025 to Treat Solid Tumors Harboring RAS Mutations
Shots: Ref: Adlai Nortye| Image: Adlai Nortye|Press Release Related News: Adlai Nortye Licenses AN9025 to ASK Pharm in a…
Read article →
Lotus Pharmaceutical Partners with Formycon to Commercialize FYB206 (Biosimilar, Keytruda) across APAC Region
Shots: Ref: Lotus | Image: Lotus & Formycon | Press Release Related News: Formycon Receives the US FDA Approval for…
Read article →
Reimagining Care Beyond Clinical Walls | Dr. Aasim Saeed | ViVE 2026 Pre-Conference Interview
Shots: About the Author Dr. Aasim Saeed Aasim Saeed is the Founder and CEO of Amenities Health. He previously worked…
Read article →
Insilico Medicine and CMS Enter Multiple Collaborations to Advance Therapeutics in CNS and Autoimmune Indications
Shots: Ref: PRnewswire | Image: Insilico & CMS | Press Release Related News: Insilico Medicine and Hygtia Therapeutics…
Read article →
The US FDA New Drug Approvals in January 2026
Shots: Company: Sentynl Therapeutics Product: Zycubo Active Ingredient: Copper Histidinate Disease: Pediatric Menkes…
Read article →
Krystal Biotech’s KB707 Receives the US FDA RMAT Designation to Treat Advanced or Metastatic NSCLC
Shots: Ref: Krystal Biotech | Image: Krystal Biotech | Press Release Related News: Krystal Biotech’s Vyjuvek (Beremagene…
Read article →
Zenas BioPharma Presents P-II (MoonStone) Trial Data on Obexelimab in Relapsing Multiple Sclerosis (RMS) at ACTRIMS Forum 2026
Shots: Ref: Globenewswire | Image: Zenas |Press Release Related News: Zenas BioPharma Enters ~$2B Deal with InnoCare…
Read article →
Takeda Receives the US FDA Priority Review for Oveporexton to Treat Narcolepsy Type 1 (NT1)
Shots: Ref: Businesswire | Image: Takeda | Press Release Related News: Iambic Therapeutics Partners with Takeda to…
Read article →